About Invitae
Invitae is a leading genetic testing company that has joined forces with Labcorp to make innovative genetic testing more accessible and actionable for patients and healthcare providers. The company's mission is to improve health and improve lives by providing comprehensive genetic information that informs every stage of life. Invitae offers broad test offerings across multiple clinical areas including oncology, women's health, pediatrics and rare diseases, cardiology, and neurology. The company has been chosen by over 5 million patients and their providers, establishing itself as a trusted source for genetic testing services. Invitae's approach combines flexible billing options, coverage by most health plans, and access to Labcorp's nationwide network of patient service centers. A key differentiator is the inclusion of genetic counseling services at no additional cost for patients in the US, US territories, and Canada. The company provides extensive clinical practice resources, including gene-specific medical management guides and result interpretation tools developed by experts based on standard medical management guidelines. These resources help healthcare providers understand test results and determine appropriate next steps for patients who test positive for genetic variants. Through its integration with Labcorp, Invitae continues to advance the field of genetics while improving patient care and access to personalized medicine.
Mission & Story
Mission
Our mission is to improve health and improve lives.
Clinical Focus
Medical conditions and clinical areas addressed by Invitae.
Who It Serves
Milestones & Awards
Recent Milestones
Acquisition by and integration with Labcorp to expand access through nationwide network of patient service centers
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 60 →
23andMe
23andMe uses AI to analyze genetic data and provide personalized health summaries, risk assessments, and wellness recommendations based on genomic insights.
2bPrecise
AI-powered precision medicine platform for personalized treatment recommendations and genomic analysis.
ACT Genomics
AI-powered genomic analysis platform for precision medicine and personalized treatment recommendations.
Adaptive Biotechnologies
Adaptive Biotechnologies uses AI and machine learning to decode the immune system and identify disease-specific immune signatures for diagnosis and personalized treatment.
Ambry Genetics
Ambry Genetics is a leading clinical genetic testing laboratory specializing in hereditary cancer, rare disease, cardiology, and neurology testing. The company provides advanced genetic testing solutions with paired DNA/RNA analysis and comprehensive patient support programs.
Ataraxis
Ataraxis develops AI-native precision medicine tools that predict patient outcomes and treatment response in oncology. Their flagship product, Ataraxis Breast, provides clinically validated prognostic and predictive tests for breast cancer using multi-modal AI analysis of pathology images and clinical data.
Avenda Health
Avenda Health develops Unfold AI, an FDA-cleared artificial intelligence platform that creates 3D cancer estimation maps for prostate cancer. The technology analyzes standard-of-care data (MRI, biopsy, pathology, PSA) to visualize cancer location and extent, helping physicians make more informed treatment decisions and improve patient outcomes.
Base Genomics
Base Genomics appears to be a company in the Precision Medicine & Genomics space, but the scraped website content is empty or inaccessible, preventing detailed analysis of their offerings and target market.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.